We have demonstrated by Nanostring and bulk RNASeq that IFNG signaling pathways are enriched in anti–CTLA-4/PD-1 colitis, but the source of IFNG message cannot be determined at a bulk RNASeq level. This evidence concerns the gene IFNG and colitis.